Tocilizumab
Anti–IL-6 receptor
- Response rate
- Temporary
- Onset
- Weeks
- Route
- SC or IV
- Line
- Alternative
- IgM effect
- Unknown
Evidence summary
IL-6 is elevated, but responses are generally incomplete or temporary — loss of efficacy over time.
Molecular targets (1)
| Molecule | Role | Expression | Evidence |
|---|---|---|---|
| IL-6 | B-cell growth factor | Elevated | strong |